Magellan To Plead Guilty, Agrees To $42M Settlement For Faulty Lead Tests
BOSTON — A Massachusetts medical device company has agreed to pay $42 million and plead guilty in a deferred prosecution agreement to resolve claims that it misled consumers and the U.S....To view the full article, register now.
Already a subscriber? Click here to view full article